|
  |
  |
 |
     |
 |
      |
  
|
The metabolic abnormalities related to intra-abdominal obesity considered to be involved in the development of cardiovascular disease include, but are not limited to components of: lipoprotein metabolism (plasma cholesterol and triglyceride transport), glucose and insulin homeostasis, blood pressure, and factors involved in thrombogenesis and inflammation.
|
